| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,436,000 | 25,082,000 | 24,230,000 | 12,089,000 | | Cost of Revenue | 905,000 | 957,000 | 999,000 | 845,000 | | | Gross Profit |
-
| 24,125,000 | 23,231,000 | 11,244,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,684,000 | 12,697,000 | 11,818,000 | 5,822,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,797,000 | 5,124,000 | 4,834,000 | 9,033,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 6,304,000 | 6,579,000 | (3,611,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,050,000 | 6,304,000 | 6,579,000 | (3,611,000) | | Interest Expense | 1,379,000 | 1,580,000 | 1,938,000 | 1,159,000 | | Income Before Tax | 4,671,000 | 4,724,000 | 4,641,000 | (4,770,000) | | Income Tax Expense | 1,355,000 | 1,475,000 | 1,552,000 | (2,036,000) | | Minority Interest |
-
| 44,000 | (44,000) |
-
| | | | Net Income From Continuing Ops | 3,026,000 | 3,293,000 | 3,045,000 | (2,734,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,114,000 | 3,293,000 | 3,045,000 | (2,734,000) | | Preferred Stock And Other Adjustments |
-
| (718,000) | (661,000) | (286,000) | | | Net Income Applicable To Common Shares | $2,637,000 | $2,575,000 | $2,384,000 | ($3,020,000) |
|
0.75% Nasdaq 
0.54 (2.08%) 
Income Statement
